The study drug is an enhanced influenza (flu) vaccination for adults 65 years and older.
Seasonal influenza, commonly known as the flu, is a contagious respiratory illness that can be severe, especially in older adults. Symptoms often include fever, cough, sore throat, and body aches.
Seasonal influenza poses a significant health risk to adults aged 65 and older, as they are more susceptible to severe complications.
This study focuses on verifying the clinical benefits of the adjuvanted vaccine for older adults. By participating, you will contribute to research that could lead to improved vaccination strategies and recommendations for this age group. Eligible participants will receive compensation for their time.
Call us on 1300 497 588 to discuss your eligibility today!